Clinical outcome in patients with acute coronary syndrome and outward remodeling is associated with a predominant inflammatory response

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Madrid Miller, Alejandra ^a   Chávez Sánchez, Luis ^b   Careaga Reyna, Guillermo ^c   Borrayo Sánchez, Gabriela ^d   Chávez Rueda, Karina ^b   Montoya Guerrero, Silvestre Armando ^a   Abundes Velazco, Arturo ^e   Ledesma Velasco, Mariano ^a   Legorreta Haquet, María Victoria ^b   Blanco Favela, Francisco ^b  

^a HOSPITAL DE CARDIOLOGÍA   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

^c Hospital General Centro Medico Nacional La Raza   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Acute coronary syndrome; Inflammation; Low density lipoprotein

Indexed keywords

ACUTE CORONARY SYNDROME; AGED; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; PATHOLOGY;

ACUTE CORONARY SYNDROME; AGED; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MALE; MIDDLE AGED;

EID: 84907970686     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-669     Document Type: Review

References (35)

1. Inflammation in atherosclerosis. Libby P, Nature 2002 420 868 874 10.1038/nature01323 12490960
2. Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound. Tardif JC, Grégoire J, L'Allier PL, Ibrahim R, Lavoie MA, LeMay M, Cohen E, Levesque S, Keller PF, Heinonen T, Guertin MC, Am J Cardiol 2006 98 23 27 10.1016/j.amjcard.2006.01.052 16784914
3. The future of intravascular ultrasound in the detection and management of coronary artery disease. Tardif JC, Can J Cardiol 2000 16 12D 15D 10932031
4. Relationship between coronary artery remodeling and plaque vulnerability. Varnava AM, Mills PG, Davies MJ, Circulation 2002 105 939 943 10.1161/hc0802.104327 11864922
5. Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina. Piek JJ, van der Wal AC, Meuwissen M, Koch KT, Chamuleau SA, Teeling P, van der Loos CM, Becker AE, J Am Coll Cardiol 2000 35 963 967 10.1016/S0735-1097(99)00647-6 10732895
6. High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. Cipollone F, Fazia M, Iezzi A, Pini B, Costantini F, De Cesare D, Paloscia L, Materazzo G, D'Annunzio E, Bucciarelli T, Vecchiet J, Chiarelli F, Cuccurullo F, Mezzetti A, Heart 2003 89 773 779 10.1136/heart.89.7.773 12807855
7. The pathogenesis of atherosclerosis: a perspective for the 1990s. Ross R, Nature 1993 362 801 809 10.1038/362801a0 8479518
8. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, Collen D, Muls E, Van de Werf F, Arterioscler Thromb Vasc Biol 2001 21 844 848 10.1161/01.ATV.21.5.844 11348884
9. Differences in human antioxidized LDL autoantibodies in patients with stable and unstable angina. Fernandes JL, Orford JL, Garcia C, Coelho OR, Gidlund M, Blotta MH, J Autoimmun 2004 23 345 352 10.1016/j.jaut.2004.08.004 15571928
10. Enhance levels of oxidized low-density lipoprotein prime monocytes to cytokine overproduction via upregulation of CD14 and Toll-like receptor 4 in unstable angina. Pasini AF, Anselmi M, Garbin U, Franchi E, Stranieri C, Nava MC, Boccioletti V, Vassanelli C, Cominacini L, Arterioscler Thromb Vasc Biol 2007 27 1991 1997 10.1161/ATVBAHA.107.142695 17600225
11. Evidence for antigen-driven T-cell response in unstable angina. Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK, Circulation 2000 10 1114 1119
12. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Stepp DW, Ou J, Ackerman AW, Welak S, Klick D, Pritchard KA Jr, Am J Physiol Heart Circ Physiol 2002 283 750 H759 12124224
13. Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB, Circulation 1997 95 1791 1798 10.1161/01.CIR.95.7.1791 9107165
14. Inhibition of the oxidative modification of LDL by nitecapone. Pentikainen MO, Lindsted KA, Kovanen PT, Arterioscler Thromb Vasc Biol 1995 15 740 747 10.1161/01.ATV.15.6.740 7773727
15. Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL. Takei A, Huang Y, Lopes-Virella MF, Atherosclerosis 2001 154 79 86 10.1016/S0021-9150(00)00465-2 11137085
16. Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response. Chávez-Sánchez L, Madrid-Miller A, Chávez-Rueda K, Legorreta-Haquet MV, Tesoro-Cruz E, Blanco-Favela F, Hum Immunol 2010 71 737 744 10.1016/j.humimm.2010.05.005 20472010
17. Impact of positive peri-stent vascular remodeling after sirolimus-eluting and paclitaxel-eluting stent implantation on 5-year clinical outcomes. Intravascular ultrasound analysis from the poststent optimal stent expansion Trial Multicenter Randomized Trial. Kang KW1, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, Hong MK, Kang WC, Ahn T, Jeon DW, Yang JY, Jang Y, Circ J 2012 76 1102 1108 10.1253/circj.CJ-11-1313 22382382
18. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Ridker PM, Circulation 2003 107 363 369 10.1161/01.CIR.0000053730.47739.3C 12551853
19. Clinical prognostic significance of plasma cystatin C levels among patients with acute coronary syndrome. Ge C, Ren F, Lu S, Ji F, Chen X, Wu X, Clin Cardiol 2009 32 644 648 10.1002/clc.20672 19938052
20. Levels of soluble adhesion molecules in patients with various clinical presentations of coronary atherosclerosis. Lu HH, Sheng ZQ, Wang Y, Zhang L, Chin Med J (Engl) 2010 123 3123 3126 21162967
21. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw KT, Arterioscler Thromb Vasc Biol 2004 24 1503 1508 10.1161/01.ATV.0000134294.54422.2e 15178568
22. Circulating transforming growth factor beta 1 and coronary artery disease. Wang XL, Liu SX, Wilcken DE, Cardiovasc Res 1997 34 404 410 10.1016/S0008-6363(97)00033-3 9205555
23. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, Tedgui A, Arterioscler Thromb Vasc Biol 1999 19 611 616 10.1161/01.ATV.19.3.611 10073964
24. Interleukin-10 inhibits postinjury tumor necrosis factor-mediated human vascular smooth muscle proliferation. Selzman CH, Meldrum DR, Cain BS, Meng X, Shames BD, Ao L, Harken AH, J Surg Res 1998 80 352 356 10.1006/jsre.1998.5486 9878337
25. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Anguera I, Miranda-Guardiola F, Bosch X, Filella X, Sitges M, Marin JL, Betriu A, Sanz G, Am Heart J 2002 144 811 817 10.1067/mhj.2002.124831 12422149
26. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Yang Z, Zingarelli B, Szabo C, Circulation 2000 101 1019 1026 10.1161/01.CIR.101.9.1019 10704170
27. TGF-β and restenosis revisited: A Smad link. Suwanabol PA, Kent KC, Liu B, J Surg Res 2011 167 287 297 10.1016/j.jss.2010.12.020 21324395
28. TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23. Morishima N, Mizoguchi I, Takeda K, Mizuguchi J, Yoshimoto T, Biochem Biophys Res Commun 2009 386 105 110 10.1016/j.bbrc.2009.05.140 19501566
29. A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. Gao Q, Jiang Y, Ma T, Zhu F, Gao F, Zhang P, Guo C, Wang Q, Wang X, Ma C, Zhang Y, Chen W, Zhang L, J Immunol 2010 185 5820 5827 10.4049/jimmunol.1000116 20952673
30. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC, Circulation 2001 104 746 749 10.1161/hc3201.094973 11502695
31. 'Danger' effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells. Zaguri R, Verbovetski I, Atallah M, Trahtemberg U, Krispin A, Nahari E, Leitersdorf E, Mevorach D, Clin Exp Immunol 2007 149 543 552 10.1111/j.1365-2249.2007.03444.x 17645766
32. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Acuto O, Michel F, Nat Rev Immunol 2003 3 939 951 10.1038/nri1248 14647476
33. The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1β, IL-6, and IL-10 secretion in human monocytes and macrophages. Chávez-Sánchez L, Chávez-Rueda K, Legorreta-Haquet MV, Zenteno E, Ledesma-Soto Y, Montoya-Díaz E, Tesoro-Cruz E, Madrid-Miller A, Blanco-Favela F, Lipids Health Dis 2010 9 117 10.1186/1476-511X-9-117 20946675
34. Oxidised LDL modulates immune-activation by an IL-12 dependent mechanism. Fei GZ, Huang YH, Swedendorg J, Frostegård J, Atherosclerosis 2003 169 77 85 10.1016/S0021-9150(03)00146-1 12860253
35. Macrophages generate reactive oxygen species in response to minimally oxidized Low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, Witztum JL, Miller YI, Circ Res 2009 104 210 218 10.1161/CIRCRESAHA.108.181040 19096031